Literature DB >> 348479

Vincristine (NSC 67574) in non-small cell bronchogenic carcinoma. Results of a phase II clinical study.

A Brugarolas, A J Lacave, A Ribas, M T Miralles.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1978        PMID： 348479     DOI： 10.1016/0014-2964(78)90252-9

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN： 0014-2964            Impact factor:   9.162


× No keyword cloud information.
  4 in total

1.  Clinical phase I and pharmacokinetic trial of vinorelbine administered as single intravenous bolus every 21 days in cancer patients.

Authors:  T Schilling; H H Fiebig; S Kerpel-Fronius; B Winterhalter; P Variol; P Tresca; B Heinrich; A R Hanauske
Journal:  Invest New Drugs       Date:  1996       Impact factor: 3.850

Review 2.  Single-agent chemotherapy for advanced adenocarcinoma of the lung. A review.

Authors:  J B Sørensen; M Clerici; H H Hansen
Journal:  Cancer Chemother Pharmacol       Date:  1988       Impact factor: 3.333

Review 3.  Microtubule Inhibitors and Cardiotoxicity.

Authors:  Amogh M Joshi; George S Prousi; Christopher Bianco; Midhun Malla; Avirup Guha; Mahek Shah; Sherry-Ann Brown; Brijesh Patel
Journal:  Curr Oncol Rep       Date:  2021-02-13       Impact factor: 5.075

4.  Cardiovascular safety profile of taxanes and vinca alkaloids: 30 years FDA registry experience.

Authors:  Arjun Ghosh; Avirup Guha; Akshee Batra; Brijesh Patel; Daniel Addison; Lauren A Baldassarre; Nihar Desai; Neal Weintraub; Anita Deswal; Zeeshan Hussain; Sherry-Ann Brown; Sarju Ganatra; Vivek Agarwala; Purvish M Parikh; Michael Fradley
Journal:  Open Heart       Date:  2021-12
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.